Literature DB >> 31894743

A Computational Study of Natural Compounds from Bacopa monnieri in the Treatment of Alzheimer's Disease.

Qazi M S Jamal1,2, Mughees U Siddiqui3, Ali H Alharbi1, Fahad Albejaidi4, Salman Akhtar2,5,6, Mohammad A Alzohairy7, Mohammad A Kamal2,8,9, Kavindra K Kesari10.   

Abstract

Keeping in view the public health-related issues of Alzheimer's disease (AD), its unpredictable occurrence and progression indicate the needs for best treatment options. The present bioinformatics study explores the binding pattern and molecular interactions between human acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) enzymes with natural compounds from Bacopa monnieri. The docking analysis between natural compounds as a ligand and AChE, BuChE as a receptor was completed using MGL tools Autodock 4.2 module. The analysis of the hydrophobic interactions, inhibition constants, and hydrogen bonds may indicates that they play a significant role in finding out the interacting position at the active site. However, after analyzing the binding energy (ΔG), the documented data shows that bacoside X, bacoside A, 3-beta-D-glucosylstigmasterol and daucosterol could be good inhibitors in the inhibition of AChE and BuChE activities. Therefore, our study indicates that the inhibition constants of the aforesaid natural compounds of Bacopa can be utilized for the development of inhibitors. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  AChE; AD; Bacopa; BuChE; docking; inhibitors.

Mesh:

Substances:

Year:  2020        PMID: 31894743     DOI: 10.2174/1381612826666200102142257

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  2 in total

1.  Soyasapogenol-B as a Potential Multitarget Therapeutic Agent for Neurodegenerative Disorders: Molecular Docking and Dynamics Study.

Authors:  Danish Iqbal; Syed Mohd Danish Rizvi; Md Tabish Rehman; M Salman Khan; Abdulaziz Bin Dukhyil; Mohamed F AlAjmi; Bader Mohammed Alshehri; Saeed Banawas; Qamar Zia; Mohammed Alsaweed; Yahya Madkhali; Suliman A Alsagaby; Wael Alturaiki
Journal:  Entropy (Basel)       Date:  2022-04-23       Impact factor: 2.738

2.  Identification of novel natural inhibitors targeting AKT Serine/Threonine Kinase 1 (AKT1) by computational study.

Authors:  Sheng Zhong; Zhiyun Zhang; Zhen Guo; Wenzhuo Yang; Gaojing Dou; Xiaye Lv; Xinhui Wang; Junliang Ge; Bo Wu; Xuefeng Pan; Hongyu Wang; Yonggao Mou
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.